Your browser doesn't support javascript.
loading
Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial.
Zhao, Ying; Yang, Yuan-Yuan; Yang, Bao-Lin; Du, Ya-Wei; Ren, Da-Wei; Zhou, Hong-Mei; Wang, Jing; Yang, Hui-Min; Wang, Yao-Xian; Zhang, Ying-Ying; Wu, Sheng-Xian.
Afiliação
  • Zhao Y; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Yang YY; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 10078, China.
  • Yang BL; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Du YW; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Ren DW; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Zhou HM; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Wang J; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Yang HM; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Wang YX; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Zhang YY; Beijing University of Chinese Medicine, Beijing, 100029, China.
  • Wu SX; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China. ljszyy@126.com.
Trials ; 22(1): 85, 2021 Jan 22.
Article em En | MEDLINE | ID: mdl-33482853

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Medicamentos de Ervas Chinesas / Dislipidemias Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Medicamentos de Ervas Chinesas / Dislipidemias Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China